The new beta-adrenergic antagonists.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000494:pharmacology*; D001262:Atenolol / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007741:Labetalol / Q000378:metabolism / Q000494:pharmacology; D008790:Metoprolol / Q000378:metabolism / Q000494:pharmacology; D009248:Nadolol; D010096:Oxprenolol / Q000378:metabolism / Q000494:pharmacology; D010869:Pindolol / Q000378:metabolism / Q000494:pharmacology; D011412:Propanolamines / Q000378:metabolism / Q000494:pharmacology; D013999:Timolol / Q000378:metabolism / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol; D001262:Atenolol; D010096:Oxprenolol; D013999:Timolol; D010869:Pindolol; D008790:Metoprolol; D007741:Labetalol